ELUCIDATING THE MECHANISM OF RECEPTOR TYROSINE KINASE INHIBITION BY SOLUBLE LRIG1 IN GLIOBLASTOMA

被引：0
|
作者：
Tiemann, Katja [1 ]
Hedman, Hakan [2 ]
Niclou, Simone P. [1 ]
机构：
[1] CRP Sante, NorLux Neurooncol Lab, Dept Oncol, Luxembourg, Luxembourg
[2] Umea Univ, Dept Radiat Sci, Umea, Sweden
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [21] LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells (vol 55, pg 1196, 2014)
    Guo, Z.
    YONSEI MEDICAL JOURNAL, 2014, 55 (06) : 1748 - 1748
  • [22] ACTIVATION OF ALTERNATIVE RECEPTOR TYROSINE KINASE IN GLIOBLASTOMA MEDIATES RESISTANCE TO PDGFR INHIBITION
    Ran, C.
    Liu, H.
    Zhang, Z.
    Israel, M. A.
    Hitoshi, Y.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (04) : 713 - 713
  • [23] The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
    Johansson, Mikael
    Oudin, Anais
    Tiemann, Katja
    Bernard, Amandine
    Golebiewska, Anna
    Keunen, Olivier
    Fack, Fred
    Stieber, Daniel
    Wang, Baofeng
    Hedman, Hakan
    Niclou, Simone P.
    NEURO-ONCOLOGY, 2013, 15 (09) : 1200 - 1211
  • [24] LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
    Gur, G
    Rubin, C
    Katz, M
    Amit, I
    Citri, A
    Nilsson, J
    Amariglio, N
    Henriksson, R
    Rechavi, G
    Hedman, H
    Wides, R
    Yarden, Y
    EMBO JOURNAL, 2004, 23 (16): : 3270 - 3281
  • [25] Inhibition of subcutaneously implanted human pituitary tumor cells in nude mice by LRIG1
    Wang, X.
    He, X. J.
    Xu, H. Q.
    Chen, Z. W.
    Fan, H. H.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02)
  • [26] Lrig1 and Lrig3 cooperate to control Ret receptor signaling, sensory axonal growth and epidermal innervation
    Paula De Vincenti, Ana
    Alsina, Fernando C.
    Ferrero Restelli, Facundo
    Hedman, Hakan
    Ledda, Fernanda
    Paratcha, Gustavo
    DEVELOPMENT, 2021, 148 (16):
  • [27] Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1
    Fan, Hengyi
    Yuan, Raorao
    Cheng, Shiqi
    Xiong, Kun
    Zhu, Xingen
    Zhang, Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 1554 - 1563
  • [28] The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases (vol 279, 47050, 2004)
    Laederich, MB
    Funes-Duran, M
    Yen, L
    Ingalla, E
    Wu, XL
    Carraway, KL
    Sweeney, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50)
  • [29] Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology
    Rogers, A. E. J.
    Le, J. P.
    Sather, S.
    Pernu, B. M.
    Graham, D. K.
    Pierce, A. M.
    Keating, A. K.
    ONCOGENE, 2012, 31 (38) : 4171 - 4181
  • [30] Mer receptor tyrosine kinase inhibition impedes glioblastoma multiforme migration and alters cellular morphology
    A E J Rogers
    J P Le
    S Sather
    B M Pernu
    D K Graham
    A M Pierce
    A K Keating
    Oncogene, 2012, 31 : 4171 - 4181
12345